Where does RareCyte, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), RareCyte, Inc. ranks #5,872 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does RareCyte, Inc. hold?

RareCyte, Inc. holds 58 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is RareCyte, Inc.'s Innovation Score?

RareCyte, Inc. has an Innovation Score of 41.6 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does RareCyte, Inc. focus on?

RareCyte, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 49 patents, ranking #297 of 7,863 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is RareCyte, Inc.'s patent grant rate increasing or decreasing?

RareCyte, Inc.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for RareCyte, Inc.'s patents?

RareCyte, Inc.'s patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the RareCyte, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

RareCyte, Inc.

USPTO PatentsView assignee record - 58 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rarecyte ranks #5,872 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 15 technology areas.

#5,872
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.6/100): 17.1
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5872 · US Corporation #5,872 · 58 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 58 grants
UPPER-Q #5,872/49,997
PHOTO-FINISH Qizhi Software…
CPC-FOCUS G01N · 15 areas
INNOV-PAR 41.6/100
CLAIMS-RICH 17.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Qizhi Software (BEIJING) Company Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rarecyte’s 41.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.1 pts (34%) Velocity 3.5 pts (8%) Breadth 13.7 pts (33%) Claim depth 10.3 pts (25%)

Qualcomm Incorporated · highest

85
Glasstech · near

42
Hitachi-Johnson… · near

42
RareCyte · this assignee

42
Riverbed Technology · near

42
Supernus Pharmaceuti… · near

42
3D Lighting… · lowest

7

What this shows Rarecyte's Innovation Score is 41.6/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rarecyte?

Each dot is one of Rarecyte’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rarecyte’s own 17.1 claims/patent is ABOVE the 5.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rarecyte vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rarecyte's grants concentrate

RareCyte, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 84.5% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2016 (10 grants) versus a trough of 1 in 2024. By volume, Rarecyte sits between Qizhi Software (BEIJING) Company Limited and Sami Labs Limited.

Rarecyte's three-year grant acceleration

RareCyte, Inc. shows 9 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Qizhi Software (B…

58
Rexon Industrial

58
Riken Technos

58
Rtic IP

58
Real Value

58
Riverpoint Medical

58
Sakata INX

58
Sami Labs

58
Rarecyte ◀

58

What this shows RareCyte holds 58 patents at rank #5,875, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near RareCyte

By rank, the assignees closest to #5,875 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in RareCyte's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for RareCyte, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), RareCyte ranks #297 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Supernus Pharmaceuticals, Inc. 42 Glasstech, Inc. 42 Riverbed Technology LLC 42 Hitachi-Johnson Controls Air Conditioning, Inc. 42

Similar claim depth

Nearest assignees by average claims per patent (17.1 here).

Global Blood Therapeutics, Inc. 17.1 avg Thermo Electron Scientific Instruments LLC 17.1 avg St. Jude Medical, LLC 17.1 avg Joby Aero, Inc. 17.1 avg

Rarecyte's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

RareCyte, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	12.1%
2016	10	17.2%
2017	5	8.6%
2018	9	15.5%
2019	7	12.1%
2020	3	5.2%
2021	7	12.1%
2022	5	8.6%
2023	3	5.2%
2024	1	1.7%
2025partial year	1	1.7%

Which technologies does RareCyte, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 49

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 30

B01D - Separation 13

Y10T - Technical Subjects Covered BY Former US Classification 11

G02B - Optical Elements, Systems OR Apparatus 11

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 3

H01L - Semiconductor Devices NOT Covered BY Class H10 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

B04B - Centrifuges 2

B03D - FLOTATION; Differential Sedimentation 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

RareCyte, Inc.'s patent record in context - here's where to go next.

RareCyte, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 84.5% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #5,872 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare RareCyte, Inc. against Qizhi Software (BEIJING) Company Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.